DaVita Inc. (dva)
DVA — Company Overview
Investors tracking DVA follow a Medical Care Facilities name listed on NYQ within Healthcare.
| Ticker | DVA |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Exchange | NYQ |
| Market cap | $11.68B |
| Last price | $183.14 |
| Size category | Large Cap |
DVA — Business Description
The business profile of DaVita Inc. (DVA) reflects its role in Medical Care Facilities. DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research program…
Official website: https://www.davita.com.
DVA — Investment Thesis
DaVita Inc. (DVA) attracts investors weighing Medical Care Facilities fundamentals against current market pricing.
- Revenue is expanding at roughly 5.2% year-over-year (public data).
- Trailing P/E of 15.57× sits in a moderate band relative to high-growth peers.
- Forward P/E (10.68×) is below trailing P/E — earnings may be expected to improve.
- Equity market capitalization is approximately $11.68B.
See the free estimates and earnings pages for public targets and growth metrics. Ownership, live news, and deeper models remain in Vest Terminal.
DVA — Financial Health
DVA financial profile reflects operating efficiency and capital structure using available market fundamentals.
Profit margin near 6.0% leaves a narrower cushion versus higher-margin peers. Positive free cash flow of $1.04B supports balance-sheet flexibility. Debt-to-equity of 1241.99 warrants monitoring in a higher-rate environment.
| Trailing P/E | 15.57× |
| Forward P/E | 10.68× |
| Price / Sales | 0.84× |
| Price / Book | -15.31× |
| Gross margin | 32.4% |
| Operating margin | 16.1% |
| Profit margin | 6.0% |
| Return on equity | 88.5% |
| Debt / Equity | 1241.99 |
| Free cash flow | $1.04B |
DVA — Growth Outlook
Growth outlook for DaVita Inc. (DVA) depends on demand trends in Medical Care Facilities and the company's ability to convert revenue into sustainable earnings.
- Revenue growth of 5.2% suggests steady but measured expansion.
- Earnings growth of 55.8% year-over-year supports improving profitability.
- Price is 26.0% below the 52-week high.
DVA — Competitive Position
DaVita Inc. (DVA) is evaluated against peers on scale, margin structure, and capital efficiency within Healthcare.
- Competes within Healthcare, specifically in Medical Care Facilities.
- Market capitalization of $11.68B places DVA among large-cap peers.
- Gross margin of 32.4% should be benchmarked against direct competitors.
DVA — Strengths
Strengths for DaVita Inc. (DVA) inferred from public financial metrics:
- Revenue growth of 5.2% year-over-year.
- Earnings growth of 55.8% year-over-year.
- Return on equity near 88.5% — efficient use of shareholder capital.
- Positive free cash flow ($1.04B).
- Large Cap scale ($11.68B) may provide distribution and funding advantages.
DVA — Weaknesses
Weaknesses and pressure points for DaVita Inc. (DVA) based on available data:
- Elevated debt-to-equity (1241.99).
- Price 26% below the 52-week high — sustained negative sentiment.
DVA — Opportunities
- Positive free cash flow enables reinvestment, debt reduction, or shareholder returns.
- Forward earnings multiple below trailing P/E — potential earnings acceleration ahead.
DVA — Risks
- Leverage (debt/equity 1241.99) raises sensitivity to credit conditions.
DVA — Summary
DaVita Inc. (DVA) is a large-cap Healthcare company focused on Medical Care Facilities, listed on NYQ. Last price $183.14 with market cap $11.68B. Trailing P/E 15.57×. Revenue grew 5.2% year-over-year per public data. Notable strengths include revenue growth of 5.2% year-over-year. Key watch items include elevated debt-to-equity (1241.99). Review free estimates and earnings pages for DVA; upgrade for institutional ownership and live headlines.
Start Free — open DVA in Vest Terminal
Access live data, filings, ownership, and analysis for DaVita Inc..
DaVita Inc. FAQ
What does DaVita Inc. (DVA) do?
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, an…
What is DVA's P/E ratio?
DaVita Inc. has a trailing P/E of 15.57× based on publicly available market data.
Does DVA pay a dividend?
Indicated dividend yield: none reported. Confirm ex-dates and payout history in Vest Terminal.
What sector is DVA in?
DaVita Inc. is classified in Healthcare (Medical Care Facilities) on NYQ.
What is DVA's market capitalization?
Approximate market cap: $11.68B.
What are the main risks for DVA?
Standard market, competitive, and execution risks apply; see the Risks section.
What are the strengths of DVA?
Potential positives include revenue growth of 5.2% year-over-year, earnings growth of 55.8% year-over-year.
Where can I get analyst estimates for DVA?
Public analyst price targets and consensus for DaVita Inc. are on the free /stocks/dva/estimates page. Deeper estimate history and models are available in Vest Terminal.